Northwest Biotherapeutics Inc. (NASDAQ:NWBO) (“NW Bio”) on 14 Aug 2014 announced the pricing of $17.5 million aggregate principal amount of its unsecured convertible notes (the “Notes”) in a private placement.The Notes are initially convertible at $7.30 per share a 10% premium above the closing market price of $6.64 per share on August 13 2014.NW Bio plans to use the offering proceeds to fund new manufacturing … Continue reading Why Need to Watch : Northwest Biotherapeutics (NASDAQ:NWBO), Akamai Technologies (NASDAQ:AKAM), Marathon Petroleum (NYSE:MPC), Learning Tree (NASDAQ:LTRE), Gramercy Property Trust (NYSE:GPT)